Why some people with COVID-19 have no symptoms
Immune cells in the lungs are important for the immune system’s recognition and fight against viruses.
But in a recent study, researchers found the virus...
This drug treatment may reduce COVID-19 death risk
In a new study, researchers found that the rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to...
Should pregnant and breastfeeding patients get the COVID-19 vaccine?
None of the COVID-19 vaccines have been studied specifically in pregnant or breastfeeding individuals. An expert addresses top questions.
As the COVID-19 vaccine starts rolling...
Scientists find a new way to predict COVID-19 outcomes
In a new study, researchers found that for COVID-19, the difference between surviving and not surviving severe disease may be due to the quality,...
This study shows 3 existing drugs could fight COVID-19 infection
In a recent study at the University of New Mexico, researchers looked through a “library” of previously approved drugs and found a drug with...
Air pollution can make COVID-19 even deadlier
In a new study, researchers found that people with long-term exposure to air pollutants may be more likely to die from COVID-19.
They analyzed more...
What’s that growing on your face mask?
COVID-19 has strongly increased the public use of face masks to protect others from the wearer’s respiratory droplets as well as the wearer from...
These people may have high risk of symptomless COVID-19 infection
In a new study, researchers found that grocery store employees are likely to be at heightened risk of COVID-19 infection, with those in customer-facing...
How COVID-19 is harming those who are not infected
The pandemic has impacted farmers, children, plant workers and even office workers in unique ways that go beyond physical illness.
In several new studies, researchers...
Scientists find long-lasting immunity after mild or asymptomatic COVID-19 infection
In a new study, researchers found evidence of protective immunity in people up to four months after mild or asymptomatic COVID-19.
They analyzed antibody and...









